Not available
Quote | Nektar Therapeutics (NASDAQ:NKTR)
Last: | $1.30 |
---|---|
Change Percent: | -3.7% |
Open: | $1.32 |
Close: | $1.35 |
High: | $1.36 |
Low: | $1.27 |
Volume: | 1,811,750 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Nektar Therapeutics (NASDAQ:NKTR)
2024-04-11 12:55:33 ET More on Mid-day movers & stocks. Nektar Therapeutics Sees Something In The Data And Puts Its Drug To The Test Nektar Therapeutics (NKTR) Q4 2023 Earnings Call Transcript Veru Inc. (VERU) Q1 2024 Earnings Call Transcript Veru gets Na...
2024-04-10 00:29:16 ET Summary Nektar Therapeutics' rezpegaldesleukin is now in two phase 2 studies, one in atopic dermatitis and one in alopecia areata. The phase 1b data in atopic dermatitis show promise, and a 400-patient phase 2 study in that indication will allow NKTR to exam...
Message Board Posts | Nektar Therapeutics (NASDAQ:NKTR)
Subject | By | Source | When |
---|---|---|---|
pincher chart on the daily and weekly, I | DavidTrader | investorshub | 03/27/2023 5:14:28 PM |
Hmmm just crickets around here, I dont mind | Lilman72003 | investorshub | 03/22/2023 8:17:33 PM |
whytestocks: $NKTR News Article - Nektar Therapeutics' President and CEO, Howard Robin, To Present a | whytestocks | investorshangout | 01/04/2023 5:25:56 PM |
whytestocks: $NKTR News Article - Nektar Therapeutics to Host Webcast Conference Call for Analysts & | whytestocks | investorshangout | 04/22/2022 6:55:51 PM |
NKTR -24%/AH on_termination_of Bempeg program following phase-3 failures | DewDiligence | investorshub | 04/14/2022 9:23:32 PM |
News, Short Squeeze, Breakout and More Instantly...
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference PR Newswire SAN FRANCISCO ,...
Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata PR Newswire SAN FRANCISCO , March 5, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a biotechnology c...
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quar...